Status:

COMPLETED

Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies

Lead Sponsor:

Washington University School of Medicine

Collaborating Sponsors:

Varian Medical Systems

Conditions:

Symptom Monitoring

Radiation Therapy

Eligibility:

All Genders

18+ years

Brief Summary

This study seeks to achieve two aims: * To assess the implementation of Noona software for continuous symptom monitoring for a diverse population of patients with thoracic malignancies who are underg...

Eligibility Criteria

Inclusion

  • Biopsy confirmed cancer. Radiographically apparent (i.e. not histologically or cytologically confirmed) malignancy of the thorax is allowed.
  • Currently planning to receive radiotherapy with or without chemotherapy for greater than one fraction.
  • Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
  • Age 18 years or older

Exclusion

  • Unable to reliably access and use a device compatible with Noona software.

Key Trial Info

Start Date :

September 3 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 13 2022

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT04324645

Start Date

September 3 2020

End Date

March 13 2022

Last Update

April 4 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110